Breakthroughs in Pancreatic Cell Replacement: The ViaCyte Interview

I recently had the opportunity to sit down with Manasi Sinha Jaiman, M.D., M.P.H., Vice President of Clinical Development, and Mark Daniels, Senior Director of Clinical Development, of ViaCyte, “a regenerative medicine company focused on delivering novel stem cell-derived cell replacement therapies as a functional cure for all type 1 diabetes and a next-generation treatment […]

Connecting Type 1 Diabetes Researchers: The Sugar Science

This content originally appeared on Beyond Type 1. Republished with permission. By Monica Westley As a scientist and a parent of a child with type 1 diabetes, I was compelled to fully understand the etiology of the disease. I created a group called “The Sugar Mamas” to connect parents to live, interactive interviews with researchers. […]

“Inverse Vaccine” to Treat Type 1 Diabetes Passes Phase I Clinical Trial

In people with type 1 diabetes (T1D), the immune system destroys the insulin-producing cells in the pancreas, leading to high blood glucose levels, which are deadly if left untreated. All people with type 1 diabetes rely on insulin injections or infusions to regulate their blood glucose levels. Individual insulin requirements are affected by many factors […]

Diabetes Research Institute and Foundation: Committed to Curing Diabetes

Learn about the mission and diabetes advocacy efforts of the Diabetes Research Institute and Foundation. Check out this summary to learn more about who they are, what they do, and more. Source: diabetesdaily.com

Is a Functional Cure for Type 1 Diabetes on the Horizon?

Have you heard about the ongoing research on cell-based therapies for type 1 diabetes? Dr. Paul Laikind is the President and CEO of ViaCyte, a company that aims to develop “a product that can free patients with type 1 and type 2 diabetes from long-term insulin dependence.” Hear more about the novel research and the recent […]